Journal of Clinical Medicine

Objective: We aimed to evaluate the morphometric characteristics of the internal acoustic meatus (IAM) using high-resolution computed tomography (CT), with emphasis on sex- and age-related differences, with particular emphasis on the IAM orientation angle as a less-studied spatial parameter and its potential clinical and forensic relevance. Methods: Temporal bone CT scans of 162 patients (94 females, 68 males; age 1–77 years) were retrospectively analyzed. Measurements included the IAM inlet diameter, length, mid-diameter, lateral angle (LA), and orientation angle. Inter-observer agreement was assessed in 30 randomly selected cases. Morphometric parameters were compared by sex and age using t-tests and Mann–Whitney U tests. Results: Mean IAM lengths were 11.0 mm (right) and 11.1 mm (left), and the mean mid-diameter was 4.2 mm bilaterally. IAM lengths and diameters showed no significant sex- or age-related differences (p > 0.05). In contrast, LA and orientation angle differed significantly by sex (p < 0.05), with females showing higher LA values, which may influence posterior fossa surgical exposure. Conclusions: IAM size parameters are largely independent of sex and age, whereas lateral and orientation angles exhibit sex-related variation. Preoperative evaluation of IAM orientation on CT can support skull base surgical planning, and LA may provide supportive morphometric information in forensic contexts, although it should not be considered a standalone sex classification parameter.

Left ventricular myocardial work (MW) has emerged as a valuable echocardiographic parameter for evaluating cardiac function and predicting clinical outcomes. Unlike conventional indices such as left ventricular ejection fraction and global longitudinal strain, MW integrates myocardial deformation with left ventricular pressure, providing a load-adjusted and physiologically meaningful assessment of myocardial performance. Growing evidence demonstrates that impaired MW is consistently associated with adverse outcomes, including heart failure hospitalization, mortality, and functional deterioration, across a wide spectrum of cardiovascular conditions such as ischemic heart disease, valvular heart disease, and cardiomyopathies. The noninvasive estimation of MW using commercially available echocardiographic software has enhanced its feasibility in routine clinical practice, enabling improved risk stratification and early identification of high-risk patients. This review summarizes current evidence supporting the prognostic value of MW, highlights its incremental role beyond conventional echocardiographic parameters, and discusses future perspectives for its integration into everyday clinical decision-making.

Background/Objectives: Hydroxychloroquine (HCQ) is used to manage various autoimmune diseases, including systemic lupus erythematosus. The prolonged use of HCQ is associated with retinopathy and irreversible visual loss due to retinal toxicity. Despite adherence to dosage regimens, patients may develop functional rather than structural changes, without detectable abnormalities on routine examination using visual acuity and optical coherence tomography (OCT). The study aimed to detect early signs of retinopathy in patients with autoimmune diseases treated with HCQ. Methods: This cross-sectional study included patients (n = 36) with autoimmune diseases who were treated with HCQ. The control group (n = 35) comprised healthy volunteers matched for age and sex. All participants were screened using colour vision tests (Ishihara, Konan ColourDX high definition [HD]), and retinal thickness was evaluated using OCT. Results: Our findings suggest a significant reduction in the contrast threshold of the L and M-cone photoreceptors compared with that of the control using Konan ColourDX HD. The OCT measurements revealed no statistically significant difference in retinal thickness between patients and controls; however, the contrast sensitivity test showed a significant reduction at all spatial frequencies (p < 0.0001). Conclusions: The current study suggests that the Konan ColourDX cone contrast test HD and contrast sensitivity testing may be valuable for periodic monitoring of patients receiving HCQ, potentially enabling earlier detection of toxicity. However, longitudinal studies with larger cohorts are needed to confirm these findings and to further establish the clinical value of these functional visual tests.